ReShape Lifesciences Inventory 2015-2024 | RSLS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ReShape Lifesciences inventory from 2015 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

ReShape Lifesciences inventory from 2015 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$197.4B
Intuitive Surgical (ISRG)	$196.1B
Alcon (ALC)	$42.2B
Edwards Lifesciences (EW)	$41.5B
IQVIA Holdings (IQV)	$35.9B
IDEXX Laboratories (IDXX)	$34.3B
DexCom (DXCM)	$29.1B
Waters (WAT)	$21.9B
STERIS (STE)	$21.3B
SONOVA HOLDING (SONVY)	$20.5B
Hologic (HOLX)	$18.3B
Fresenius Medical Care AG KGaA (FMS)	$12.9B
Sysmex ADR (SSMXY)	$12.8B
Globus Medical (GMED)	$11.6B
Penumbra (PEN)	$9.2B
Masimo (MASI)	$9.1B
Teleflex (TFX)	$8.9B
Glaukos (GKOS)	$7.8B
PROCEPT BioRobotics (PRCT)	$4.9B
Integer Holdings (ITGR)	$4.6B
Veracyte (VCYT)	$3B
Inari Medical (NARI)	$2.9B
LivaNova (LIVN)	$2.8B
TransMedics (TMDX)	$2.7B
Nihon Kohden (NHNKY)	$2.4B
Elekta AB (EKTAY)	$2.1B
Tandem Diabetes Care (TNDM)	$2B
RxSight (RXST)	$1.8B
Integra LifeSciences Holdings (IART)	$1.8B
Alphatec Holdings (ATEC)	$1.4B